Breaking News Instant updates and real-time market news.

MDT

Medtronic

$90.83

-0.04 (-0.04%)

09:08
08/09/18
08/09
09:08
08/09/18
09:08

Medtronic begins pilot study of EV ICD system

Medtronic announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and antitachycardia pacing therapy all in one system, with a device size similar to transvenous ICDs. The first patient implant was performed at Christchurch Hospital in New Zealand, representing the first intended long-term patient use of the Medtronic EV ICD system. The EV ICD system is investigational and not approved for sale or distribution. The pilot study will assess the Medtronic EV ICD system in 20 patients at four sites: Christchurch Hospital; Austin Health in Heidelberg, Australia; MonashHeart in Clayton, Australia; and The Prince Charles Hospital in Brisbane, Australia. After implantation of the system, patients and their devices will be routinely checked to assess safety and device performance.

  • 14

    Aug

  • 15

    Aug

  • 23

    Aug

MDT Medtronic
$90.83

-0.04 (-0.04%)

06/27/18
BERN
06/27/18
INITIATION
Target $88
BERN
Market Perform
Medtronic initiated with a Market Perform at Bernstein
Bernstein analyst Lee Hambright started Medtronic with a Market Perform rating and $88 price target as he believes the company is undergoing "something of an identity crisis." After ardent pursuit of economic value and globalization strategies over the past 7 years, Medtronic messaging has recently shifted, with greater emphasis on technology leadership, he contends. The analyst believes the new messaging is the right move for the company, but thinks the stock is unlikely to work until the company can demonstrate consistent performance on margin and cash conversion commitments.
06/26/18
BMOC
06/26/18
NO CHANGE
Target $94
BMOC
Outperform
Medtronic Sugar IQ software 'underappreciated', says BMO Capital
BMO Capital analyst Joanne Wuensch kept her Outperform rating and $94 price target on Medtronic after its Diabetes Analyst Meeting at ADA yesterday. The analyst cites the company's message that it is investing in a comprehensive program to better treat diabetes patients while focusing on systems to reduce healthcare costs, having raised its market share and decreased preventable hospitalizations. Wuensch also believes that Medtronic's Sugar IQ software is underappreciated given its ability to start providing "customizable insights to patients after just five days of data collection".
06/18/18
PIPR
06/18/18
NO CHANGE
Target $96
PIPR
Overweight
Piper continues to recommend Medtronic after management meeting
After meeting with management, Piper Jaffray analyst Matt O'Brien continues to recommend building positions in Medtronic (MDT). The analyst views management's 4% plus revenue outlook over the next several years as "readily achievable and likely conservative." Management noted that given the low penetration rates of surgery performed on robots, they did not see a reason to be aggressive on pricing of their system once they get it to market, O'Brien tells investors in a research note. He believes that is a positive comment for Intuitive Surgical (ISRG). The analyst keeps an Overweight rating on Medtronic with a $96 price target.
06/11/18
PIPR
06/11/18
NO CHANGE
Target $32.5
PIPR
Overweight
Piper doesn't see regulatory issues for possible Stryker, Boston Scientific deal
Piper Jaffray analyst Matt O'Brien believes regulatory constraints from Stryker's (SYK) potential acquisition of Boston Scientific (BSX) "should not be much of an issue" given the little overlap between the businesses. The deal structure would be the biggest issue facing Stryker as the company would likely have to lever up heavily to acquire Boston Scientific, O'Brien tells investors in a research note. The analyst believes a transaction could occur in the $52B-$54B range, assuming a typical medtech takeout premium of 20%-30%. Consequently, any transaction would either require a significant level of debt or dilution to Stryker shareholders, the analyst contends. He sees the potential deal as likely being dilutive until 2021. O'Brien has an Overweight rating on Boston Scientific with a $32.50 price target. The stock closed the trading day up 7% to $34.32 after the Wall Street Journal reported that Stryker approached the company regarding a takeover.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$259.65

-0.96 (-0.37%)

12:38
12/17/18
12/17
12:38
12/17/18
12:38
Hot Stocks
Gundlach says China, U.S. trade war getting worse »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$259.65

-0.96 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$259.83

-0.78 (-0.30%)

, SPX

S&P 500

$0.00

(0.00%)

12:34
12/17/18
12/17
12:34
12/17/18
12:34
Hot Stocks
Gundlach reiterates view that next big move for U.S. dollar is down »

Jeffrey Gundlach of…

SPY

SPDR S&P 500 ETF Trust

$259.83

-0.78 (-0.30%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$259.90

-0.71 (-0.27%)

, SPX

S&P 500

$0.00

(0.00%)

12:32
12/17/18
12/17
12:32
12/17/18
12:32
Hot Stocks
Hearings, investigations into Trump 'building uncertainty,' says Gundlach »

Jeffrey Gundlach of…

SPY

SPDR S&P 500 ETF Trust

$259.90

-0.71 (-0.27%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$65.34

0.02 (0.03%)

12:30
12/17/18
12/17
12:30
12/17/18
12:30
Options
Sweep buyers of Starbucks Dec 64 calls »

Sweep buyers of Starbucks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$120.17

-7.38 (-5.79%)

, MOH

Molina Healthcare

$115.51

-16.21 (-12.31%)

12:25
12/17/18
12/17
12:25
12/17/18
12:25
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened deep in…

CNC

Centene

$120.17

-7.38 (-5.79%)

MOH

Molina Healthcare

$115.51

-16.21 (-12.31%)

WCG

WellCare

$237.31

0.41 (0.17%)

GS

Goldman Sachs

$170.86

-1.94 (-1.12%)

JACK

Jack in the Box

$83.25

3.03 (3.78%)

PTI

Proteostasis

$5.05

0.235 (4.89%)

RHHBY

Roche

$0.00

(0.00%)

ACHC

Acadia

$27.47

-1.43 (-4.95%)

UHS

Universal Health

$119.65

-1.34 (-1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 05

    Feb

  • 18

    Mar

12:25
12/17/18
12/17
12:25
12/17/18
12:25
General news
Doubleline's Gundlach said this "seems to be a bear market" »

Doubleline's…

NVAX

Novavax

$2.33

-0.095 (-3.93%)

12:20
12/17/18
12/17
12:20
12/17/18
12:20
Options
Novavax calls lead puts 40:1 after a strong week »

Novavax calls lead puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$54.54

3.12 (6.07%)

12:18
12/17/18
12/17
12:18
12/17/18
12:18
Recommendations
XPO Logistics analyst commentary  »

Deutsche says change…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/17/18
12/17
12:17
12/17/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/17/18
12/17
12:16
12/17/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$13.54

-0.23 (-1.67%)

12:15
12/17/18
12/17
12:15
12/17/18
12:15
Conference/Events
Yeti management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

  • 14

    Jan

AGNC

AGNC Investment

$18.03

0.01 (0.06%)

12:15
12/17/18
12/17
12:15
12/17/18
12:15
Options
AGNC Investment Corp. put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.32

-0.29 (-0.11%)

12:14
12/17/18
12/17
12:14
12/17/18
12:14
Hot Stocks
Gundlach says Federal Reserve should not raise rates this week »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.32

-0.29 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.08

-0.53 (-0.20%)

12:11
12/17/18
12/17
12:11
12/17/18
12:11
Hot Stocks
Gundlach sees 10-year treasury at 6% by 2021 »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.08

-0.53 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$260.00

-0.61 (-0.23%)

, SPX

S&P 500

$0.00

(0.00%)

12:08
12/17/18
12/17
12:08
12/17/18
12:08
Hot Stocks
Almost no real economic growth happening away from deficit, Gundlach says »

Jeffrey Gundlach of…

SPY

SPDR S&P 500 ETF Trust

$260.00

-0.61 (-0.23%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PINC

Premier

$37.80

-0.09 (-0.24%)

12:08
12/17/18
12/17
12:08
12/17/18
12:08
Conference/Events
Premier management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

BBY

Best Buy

$54.14

-1.23 (-2.22%)

, AAPL

Apple

$167.64

2.16 (1.31%)

12:07
12/17/18
12/17
12:07
12/17/18
12:07
On The Fly
Best Buy slips after BofA downgrades to 'sell' on concerns of slowing industry growth »

Shares of Best Buy (BBY)…

BBY

Best Buy

$54.14

-1.23 (-2.22%)

AAPL

Apple

$167.64

2.16 (1.31%)

BAC

Bank of America

$24.84

0.35 (1.43%)

AMZN

Amazon.com

$1,562.32

-29.82 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 04

    Jan

  • 07

    Jan

  • 12

    Feb

AXP

American Express

$103.75

-1.98 (-1.87%)

12:06
12/17/18
12/17
12:06
12/17/18
12:06
Hot Stocks
American Express reports November net write-off rate 2.0% vs. 2.0% last month »

Reports November 30 days…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.04

-0.57 (-0.22%)

12:06
12/17/18
12/17
12:06
12/17/18
12:06
Hot Stocks
Gundlach thinks bear market 'lasts a long time' »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.04

-0.57 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

12:05
12/17/18
12/17
12:05
12/17/18
12:05
Hot Stocks
Gundlach says VIX 'disturbing' as its not going higher »

Jeffrey Gundlach of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$39.55

0.4 (1.02%)

12:05
12/17/18
12/17
12:05
12/17/18
12:05
Options
Campbell Soup call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMUF

Basilea Pharmaceutica

$0.00

(0.00%)

12:03
12/17/18
12/17
12:03
12/17/18
12:03
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$259.57

-1.04 (-0.40%)

12:02
12/17/18
12/17
12:02
12/17/18
12:02
Hot Stocks
Jeffrey Gundlach says 'pretty sure' stocks in bear market »

Jeffrey Gundlach of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$259.57

-1.04 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTCH

Farfetch

$21.37

-2.45 (-10.29%)

12:00
12/17/18
12/17
12:00
12/17/18
12:00
Hot Stocks
Farfetch falls -10.6% »

Farfetch is down -10.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$81.00

-11 (-11.96%)

12:00
12/17/18
12/17
12:00
12/17/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -11.8% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.